Clinical Trials
6 trialsNCT06599762 2026-04-22
MYELO-CAN:TXA
University of Manitoba
Phase 2 Recruiting
NCT04631211 2023-05-25
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Cellphire Therapeutics, Inc.
Phase 2 Terminated
NCT03303950 2022-05-05
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
University of Utah
Phase 2 Terminated
NCT03195010 2019-10-21
Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia
Fred Hutchinson Cancer Center
Phase 2 Terminated
NCT01440374 2017-06-05
ASPIRE
Novartis
Phase 2 Completed
NCT00493181 2012-02-20
Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients
M.D. Anderson Cancer Center
Phase 2 Completed